Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesCost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer
Annals of Oncology, 10/20/09
Sher DJ et al. – Patients with node–positive head and neck squamous cell carcinomas (HNC) have a significant risk of residual disease (RD) in the neck after treatment, despite optimal chemoradiotherapy (CRT). Adjuvant neck dissection (ND) after CRT has been considered standard treatment, but its morbidity has led investigators to consider using post–CRT imaging to determine the need for surgery. Adjuvant ND reserved for patients with RD on PET–CT is the dominant and cost–effective strategy.
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer
Thyroid, 11/02/09
Regional anaesthesia for head and neck surgery
Annales Françaises d'Anesthésie et de Réanimation , 10/30/09
Continued alcohol use in patients with head and neck cancer
Head & Neck, 11/18/09
Sponsor
Article Search
Sponsor